Drug General Information (ID: D1645)
  Drug Name
Trimethoprim
  Drug Type Small molecule
  Drug Synonymous
Abaprim; Alprim; Anitrim; Antrima; Antrimox; Bacdan; Bacidal; Bacide; Bacin; Bacta; Bacterial; Bacticel; Bactin; Bactoprim; Bactramin; Bencole; Bethaprim; Biosulten; Briscotrim; Chemotrin; Cidal; Colizole; Conprim; Cotrimel; Deprim; Duocide; Esbesul; Espectrin; Euctrim; Exbesul; Fermagex; Fortrim; Futin; Idotrim; Ikaprim; Instalac; Kombinax; Lagatrim; Lastrim; Methoprim; Metoprim; Monoprim; Monotrim; Monotrimin; Novotrimel; Omstat; Oraprim; Pancidim; Polytrim; Priloprim; Primosept; Primsol; Proloprim; Protrin; Purbal; Resprim; Roubac; Roubal; Salvatrim; Setprin; Sinotrim; Stopan; Streptoplus; Sugaprim; Sulfamar; Sulfamethoprim; Sulfoxaprim; Sulmeprim; Sulthrim; Sultrex; Syraprim; Tiempe; Toprim; Trimanyl; Trimethioprim; Trimethoprime; Trimethoprimum; Trimethopriom; Trimetoprim; Trimetoprima; Trimexazole; Trimexol; Trimezol; Trimogal; Trimono; Trimopan; Trimpex; Triprim; Trisul; Trisulcom; Trisulfam; Trisural; Uretrim; Urobactrim; Utetrin; Velaten; Wellcoprim; Wellcoprin; Xeroprim; Zamboprim; Bacterial [Antibiotic]; Colizole DS; Component of Bactrim; Component of Septra; Lagatrim Forte; ResprimForte; Septrin DS; Septrin Forte; Septrin S; Trimetoprim [DCIT]; Trimetoprim [Polish]; BW 5672; KUC103659N; NIH 204; T 7883; Trimpex 200; WR 5949; Alcorim-F; Apo-Sulfatrim; BW 56-72; Co-Trimoxizole; Monotrim (TN); NIH 204 (VAN); Proloprim (TN); Smz-Tmp; Sulfamethoxazole & Trimethoprim; TCMDC-125538; Tmp-Ratiopharm; Trimeth/Sulfa; Trimethopim(TMP); Trimethoprim & VRC3375; Trimethoprime [INN-French]; Trimethoprimum [INN-Latin]; Trimetoprima [INN-Spanish]; Trimez-IFSA; Trimpex (TN); Triprim (TN); U-Prin; Uro-D S; BW-56-72; KSC-4-158; AZT + TMP/SMX (mixture) combination; Trimethoprim (JAN/USP/INN); Trimethoprim [USAN:BAN:INN:JAN]
    Click to Show/Hide
  Disease Class GC08: Urinary tract infection
  Therapeutic Class Antiinfective Agents
  Structure Could Not Find 2D Structure
3D Structure 2D Structure
  Formula C14H18N4O3
  InChI 1S/C14H18N4O3/c1-19-10-5-8(6-11(20-2)12(10)21-3)4-9-7-17-14(16)18-13(9)15/h5-7H,4H2,1-3H3,(H4,15,16,17,18)
  InChIKey IEDVJHCEMCRBQM-UHFFFAOYSA-N
  Canonical SMILES COC1=CC(=CC(=C1OC)OC)CC2=CN=C(N=C2N)N
  External Link
Pubchem ID 5578
CAS Number 738-70-5
CHEBI ID 45924
TTD ID D0AO5H
INTEDE ID DR1648
VARIDT ID DR00590

Drug-Drug Interaction Network
  Sunburst Graph
AM002  Affected cellular transport
AM003  Affected organization distribution
AM004  Affected intra/extra-hepatic metabolism
AM005  Affected excretion pathways
AM006  Pharmacodynamic additive effects
AM007  Pharmacodynamic antagonistic effects
BM010  Transporter inhibition
BM014  Interference of cell/tissue uptake
BM017  CYP450 enzyme inhibition
BM022  CYP450 enzyme induction
BM026  Increased metabolism (Unspecific)
BM028  Competitive inhibition of renal tubular secretion
BM032  Decreased renal excretion (Unspecific)
BM044  Additive myelosuppressive effects
BM050  Increased risk of bleeding
BM058  Increased risk of hyperkalemia
BM072  Increased risk of nephrotoxicity
BM075  Increased risk of photosensitivity reactions
BM076  Increased risk of prolong QT interval
BM083  Potentiated the pharmacological effects (Unspecific)
BM100  Antagonize the effect of vaccine/toxoid
BM107  Attenuated pharmacological effects (Unspecific)
  Relation Graph
 Full list of drugs interacting with Trimethoprim
      Affected cellular transport
   Transporter inhibition Drug Num:  7
Drug ID
 
Drug Name
Formula Pubchem ID Severity Level Interaction Detail REF
D0513
 
Dofetilide
 
C19H27N3O5S2
 
71329 
Major    Inter Info   
[1], [2], [3]
D1015
 
Metformin
 
C4H11N5
 
4091 
Moderate    Inter Info   
[51], [52]
D0051
 
Amantadine
 
C10H17N
 
2130 
Moderate    Inter Info   
[46], [42], [24]
D0182
 
Binimetinib
 
C17H15BrF2N4O3
 
10288191 
Moderate    Inter Info   
[46], [42], [80]
D0412
 
Dalfampridine
 
C5H6N2
 
1727 
Moderate    Inter Info   
[46], [42], [84]
D0963
 
Lusutrombopag
 
C29H32Cl2N2O5S
 
49843517 
Moderate    Inter Info   
[89]
D0998
 
Memantine
 
C12H21N
 
4054 
Moderate    Inter Info   
[46], [42], [24]
      Affected organization distribution
   Interference of cell/tissue uptake Drug Num:  1
Drug ID
 
Drug Name
Formula Pubchem ID Severity Level Interaction Detail REF
D1817
 
Indium In-111 oxyquinoline
 
C27H18InN3O3
 
16685037 
Moderate    Inter Info   
[88]
      Affected intra/extra-hepatic metabolism
   CYP450 enzyme inhibition Drug Num:  13
Drug ID
 
Drug Name
Formula Pubchem ID Severity Level Interaction Detail REF
D1283
 
Phenytoin
 
C15H12N2O2
 
1775 
Moderate    Inter Info   
[53], [46], [54], [42], [55], [56], [57], [58], [59], [60], [24], [61], [62], [63], [64]
D1429
 
Rosiglitazone
 
C18H19N3O3S
 
77999 
Moderate    Inter Info   
[66], [67], [68], [69], [70], [71], [63]
D1625
 
Treprostinil
 
C23H34O5
 
6918140 
Moderate    Inter Info   
[73]
D0621
 
Ethotoin
 
C11H12N2O2
 
3292 
Moderate    Inter Info   
[56], [57]
D0697
 
Fosphenytoin
 
C16H15N2O6P
 
56339 
Moderate    Inter Info   
[53], [46], [54], [42], [55], [56], [57], [58], [59], [60], [24], [61], [62], [63], [64]
D1003
 
Mephenytoin
 
C12H14N2O2
 
4060 
Moderate    Inter Info   
[56], [57]
D1087
 
Montelukast
 
C35H36ClNO3S
 
5281040 
Moderate    Inter Info   
[90], [91]
D1212
 
Paclitaxel
 
C47H51NO14
 
36314 
Moderate    Inter Info   
[92], [93], [46], [94], [95], [96], [97], [98]
D1213
 
Paclitaxel (protein-bound)
 
C47H51NO14
 
36314 
Moderate    Inter Info   
[92], [93], [46]
D1294
 
Pioglitazone
 
C19H20N2O3S
 
4829 
Moderate    Inter Info   
[102], [103], [104], [105], [106], [107], [71], [108], [63]
D1392
 
Repaglinide
 
C27H36N2O4
 
65981 
Moderate    Inter Info   
[114], [115], [116], [117], [63]
D1457
 
Selexipag
 
C26H32N4O4S
 
9913767 
Moderate    Inter Info   
[118]
D1660
 
Tucatinib
 
C26H24N8O2
 
51039094 
Moderate    Inter Info   
[120]
   CYP450 enzyme induction Drug Num:  7
Drug ID
 
Drug Name
Formula Pubchem ID Severity Level Interaction Detail REF
D0255
 
Carbamazepine
 
C15H12N2O
 
2554 
Moderate    Inter Info   
[81], [82], [83]
D0578
 
Enzalutamide
 
C21H16F4N4O2S
 
15951529 
Moderate    Inter Info   
[81], [82], [83]
D0958
 
Lumacaftor
 
C24H18F2N2O5
 
16678941 
Moderate    Inter Info   
[81], [82], [83]
D1265
 
Phenobarbital
 
C12H12N2O3
 
4763 
Moderate    Inter Info   
[81], [82], [83]
D1340
 
Primidone
 
C12H14N2O2
 
4909 
Moderate    Inter Info   
[81], [82], [83]
D1401
 
Rifapentine
 
C47H64N4O12
 
135403821 
Moderate    Inter Info   
[81], [82], [83]
D1502
 
St. John's Wort
 
NA
 
NA
Moderate    Inter Info   
[81], [82], [83]
   Increased metabolism (Unspecific) Drug Num:  1
Drug ID
 
Drug Name
Formula Pubchem ID Severity Level Interaction Detail REF
D1802
 
Glucarpidase
 
Zn4+8
 
21195079 
Moderate    Inter Info   
[42], [87]
      Affected excretion pathways
   Competitive inhibition of renal tubular secretion Drug Num:  6
Drug ID
 
Drug Name
Formula Pubchem ID Severity Level Interaction Detail REF
D1343
 
Procainamide
 
C13H21N3O
 
4913 
Moderate    Inter Info   
[111], [112], [113]
D1715
 
Zalcitabine
 
C9H13N3O3
 
24066 
Moderate    Inter Info   
[42], [65], [121]
D1768
 
Creatine
 
C4H9N3O2
 
586 
Minor    Inter Info   
[122], [123], [124]
D0491
 
Digoxin
 
C41H64O14
 
2724385 
Minor    Inter Info   
[125], [126], [127]
D0710
 
Ganciclovir
 
C9H13N5O4
 
135398740 
Minor    Inter Info   
[46], [42], [132]
D1676
 
Valganciclovir
 
C14H22N6O5
 
135413535 
Minor    Inter Info   
[46], [42], [132]
   Decreased renal excretion (Unspecific) Drug Num:  1
Drug ID
 
Drug Name
Formula Pubchem ID Severity Level Interaction Detail REF
D1293
 
Pindolol
 
C14H20N2O2
 
4828 
Minor    Inter Info   
[133]
      Pharmacodynamic additive effects
   Additive myelosuppressive effects Drug Num:  2
Drug ID
 
Drug Name
Formula Pubchem ID Severity Level Interaction Detail REF
D0136
 
Azathioprine
 
C9H7N7O2S
 
2265 
Moderate    Inter Info   
[75], [76], [77], [46], [42], [78]
D1007
 
Mercaptopurine
 
C5H4N4S
 
667490 
Moderate    Inter Info   
[75], [76], [77], [46], [42], [78]
   Increased risk of bleeding Drug Num:  3
Drug ID
 
Drug Name
Formula Pubchem ID Severity Level Interaction Detail REF
D0481
 
Dicoumarol
 
C19H12O6
 
54676038 
Moderate    Inter Info   
[47], [42], [48]
D0087
 
Anisindione
 
C16H12O3
 
2197 
Moderate    Inter Info   
[74], [42]
D1711
 
Warfarin
 
C19H16O4
 
54678486 
Moderate    Inter Info   
[74], [42]
   Increased risk of hyperkalemia Drug Num:  31
Drug ID
 
Drug Name
Formula Pubchem ID Severity Level Interaction Detail REF
D1170
 
Olmesartan
 
C24H26N6O3
 
158781 
Major    Inter Info   
[4], [5], [6], [7], [8], [9], [10], [11], [12], [13], [14], [15], [16], [17], [18], [19], [20], [21], [22], [23], [24], [25], [26], [27], [28], [29], [30], [31], [32], [33], [34], [35], [36], [37], [38]
D1379
 
Ramipril
 
C23H32N2O5
 
5362129 
Major    Inter Info   
[4], [5], [21], [31], [12], [13], [32], [33], [8], [17], [34], [35], [22], [36], [14], [28], [29], [30], [16], [37], [38], [25], [27], [6], [7], [9], [10], [11], [15], [18], [19], [20], [23], [24], [26]
D1501
 
Spironolactone
 
C24H32O4S
 
5833 
Major    Inter Info   
[4], [5], [6], [7], [8], [9], [10], [11], [12], [13], [14], [15], [16], [17], [18], [19], [20], [21], [22], [23], [24], [25], [26], [27], [28], [29], [30], [31], [32], [33], [34], [35], [36], [37], [38]
D1631
 
Triamterene
 
C12H11N7
 
5546 
Major    Inter Info   
[4], [5], [6], [7], [8], [9], [10], [11], [12], [13], [14], [15], [16], [17], [18], [19], [20], [21], [22], [23], [24], [25], [26], [27], [28], [29], [30], [31], [32], [33], [34], [35], [36], [37], [38]
D0058
 
Amiloride
 
C6H8ClN7O
 
16231 
Major    Inter Info   
[4], [5], [6], [7], [8], [9], [10], [11], [12], [13], [14], [15], [16], [17], [18], [19], [20], [21], [22], [23], [24], [25], [26], [27], [28], [29], [30], [31], [32], [33], [34], [35], [36], [37], [38]
D0138
 
Azilsartan medoxomil
 
C30H24N4O8
 
135409642 
Major    Inter Info   
[4], [5], [6], [7], [8], [9], [10], [11], [12], [13], [14], [15], [16], [17], [18], [19], [20], [21], [22], [23], [24], [25], [26], [27], [28], [29], [30], [31], [32], [33], [34], [35], [36], [37], [38]
D0156
 
Benazepril
 
C24H28N2O5
 
5362124 
Major    Inter Info   
[4], [5], [6], [7], [8], [9], [10], [11], [12], [13], [14], [15], [16], [17], [18], [19], [20], [21], [22], [23], [24], [25], [26], [27], [28], [29], [30], [31], [32], [33], [34], [35], [36], [37], [38]
D0254
 
Captopril
 
C9H15NO3S
 
44093 
Major    Inter Info   
[4], [5], [6], [7], [8], [9], [10], [11], [12], [13], [14], [15], [16], [17], [18], [19], [20], [21], [22], [23], [24], [25], [26], [27], [28], [29], [30], [31], [32], [33], [34], [35], [36], [37], [38]
D0567
 
Enalapril
 
C20H28N2O5
 
5388962 
Major    Inter Info   
[4], [5], [6], [7], [8], [9], [10], [11], [12], [13], [14], [15], [16], [17], [18], [19], [20], [21], [22], [23], [24], [25], [26], [27], [28], [29], [30], [31], [32], [33], [34], [35], [36], [37], [38]
D0585
 
Eplerenone
 
C24H30O6
 
443872 
Major    Inter Info   
[4], [5], [6], [7], [8], [9], [10], [11], [12], [13], [14], [15], [16], [17], [18], [19], [20], [21], [22], [23], [24], [25], [26], [27], [28], [29], [30], [31], [32], [33], [34], [35], [36], [37], [38]
D0587
 
Eprosartan
 
C23H24N2O4S
 
5281037 
Major    Inter Info   
[4], [5], [6], [7], [8], [9], [10], [11], [12], [13], [14], [15], [16], [17], [18], [19], [20], [21], [22], [23], [24], [25], [26], [27], [28], [29], [30], [31], [32], [33], [34], [35], [36], [37], [38]
D0695
 
Fosinopril
 
C30H46NO7P
 
55891 
Major    Inter Info   
[4], [5], [6], [7], [8], [9], [10], [11], [12], [13], [14], [15], [16], [17], [18], [19], [20], [21], [22], [23], [24], [25], [26], [27], [28], [29], [30], [31], [32], [33], [34], [35], [36], [37], [38]
D0844
 
Irbesartan
 
C25H28N6O
 
3749 
Major    Inter Info   
[4], [5], [21], [31], [12], [13], [32], [33], [8], [17], [34], [35], [22], [36], [14], [28], [29], [30], [16], [37], [38], [25], [27], [6], [7], [9], [10], [11], [15], [18], [19], [20], [23], [24], [26]
D0938
 
Lisinopril
 
C21H31N3O5
 
5362119 
Major    Inter Info   
[4], [5], [6], [7], [8], [9], [10], [11], [12], [13], [14], [15], [16], [17], [18], [19], [20], [21], [22], [23], [24], [25], [26], [27], [28], [29], [30], [31], [32], [33], [34], [35], [36], [37], [38]
D0954
 
Losartan
 
C22H23ClN6O
 
3961 
Major    Inter Info   
[4], [5], [6], [7], [8], [9], [10], [11], [12], [13], [14], [15], [16], [17], [18], [19], [20], [21], [22], [23], [24], [25], [26], [27], [28], [29], [30], [31], [32], [33], [34], [35], [36], [37], [38]
D1082
 
Moexipril
 
C27H34N2O7
 
91270 
Major    Inter Info   
[4], [5], [6], [7], [8], [9], [10], [11], [12], [13], [14], [15], [16], [17], [18], [19], [20], [21], [22], [23], [24], [25], [26], [27], [28], [29], [30], [31], [32], [33], [34], [35], [36], [37], [38]
D1086
 
Monopotassium phosphate
 
H2KO4P
 
516951 
Major    Inter Info   
[21], [5], [4]
D1256
 
Perindopril
 
C19H32N2O5
 
107807 
Major    Inter Info   
[4], [5], [6], [7], [8], [9], [10], [11], [12], [13], [14], [15], [16], [17], [18], [19], [20], [21], [22], [23], [24], [25], [26], [27], [28], [29], [30], [31], [32], [33], [34], [35], [36], [37], [38]
D1316
 
Potassium acetate
 
C2H3KO2
 
517044 
Major    Inter Info   
[4], [5], [6], [7], [8], [9], [10], [11], [12], [13], [14], [15], [16], [17], [18], [19], [20], [21], [22], [23], [24], [25], [26], [27], [28], [29], [30], [31], [32], [33], [34], [35], [36], [37], [38]
D1317
 
Potassium bicarbonate
 
CHKO3
 
516893 
Major    Inter Info   
[4], [5], [6], [7], [8], [9], [10], [11], [12], [13], [14], [15], [16], [17], [18], [19], [20], [21], [22], [23], [24], [25], [26], [27], [28], [29], [30], [31], [32], [33], [34], [35], [36], [37], [38]
D1318
 
Potassium chloride
 
ClK
 
4873 
Major    Inter Info   
[4], [5], [6], [7], [8], [9], [10], [11], [12], [13], [14], [15], [16], [17], [18], [19], [20], [21], [22], [23], [24], [25], [26], [27], [28], [29], [30], [31], [32], [33], [34], [35], [36], [37], [38]
D1319
 
Potassium citrate
 
C6H5K3O7
 
13344 
Major    Inter Info   
[4], [5], [6], [7], [8], [9], [10], [11], [12], [13], [14], [15], [16], [17], [18], [19], [20], [21], [22], [23], [24], [25], [26], [27], [28], [29], [30], [31], [32], [33], [34], [35], [36], [37], [38]
D1320
 
Potassium gluconate
 
C6H11KO7
 
16760467 
Major    Inter Info   
[4], [5], [6], [7], [8], [9], [10], [11], [12], [13], [14], [15], [16], [17], [18], [19], [20], [21], [22], [23], [24], [25], [26], [27], [28], [29], [30], [31], [32], [33], [34], [35], [36], [37], [38]
D1321
 
Potassium Iodide
 
IK
 
4875 
Major    Inter Info   
[4], [5], [6], [7], [8], [9], [10], [11], [12], [13], [14], [15], [16], [17], [18], [19], [20], [21], [22], [23], [24], [25], [26], [27], [28], [29], [30], [31], [32], [33], [34], [35], [36], [37], [38]
D1322
 
Potassium perchlorate
 
ClKO4
 
516900 
Major    Inter Info   
[4], [5], [6], [7], [8], [9], [10], [11], [12], [13], [14], [15], [16], [17], [18], [19], [20], [21], [22], [23], [24], [25], [26], [27], [28], [29], [30], [31], [32], [33], [34], [35], [36], [37], [38]
D1369
 
Quinapril
 
C25H30N2O5
 
54892 
Major    Inter Info   
[4], [5], [21], [31], [12], [13], [32], [33], [8], [17], [34], [35], [22], [36], [14], [28], [29], [30], [16], [37], [38], [25], [27], [6], [7], [9], [10], [11], [15], [18], [19], [20], [23], [24], [26]
D1545
 
Telmisartan
 
C33H30N4O2
 
65999 
Major    Inter Info   
[4], [5], [6], [7], [8], [9], [10], [11], [12], [13], [14], [15], [16], [17], [18], [19], [20], [21], [22], [23], [24], [25], [26], [27], [28], [29], [30], [31], [32], [33], [34], [35], [36], [37], [38]
D1618
 
Trandolapril
 
C24H34N2O5
 
5484727 
Major    Inter Info   
[4], [5], [6], [7], [8], [9], [10], [11], [12], [13], [14], [15], [16], [17], [18], [19], [20], [21], [22], [23], [24], [25], [26], [27], [28], [29], [30], [31], [32], [33], [34], [35], [36], [37], [38]
D1679
 
Valsartan
 
C24H29N5O3
 
60846 
Major    Inter Info   
[4], [5], [6], [7], [8], [9], [10], [11], [12], [13], [14], [15], [16], [17], [18], [19], [20], [21], [22], [23], [24], [25], [26], [27], [28], [29], [30], [31], [32], [33], [34], [35], [36], [37], [38]
D0536
 
Drospirenone
 
C24H30O3
 
68873 
Moderate    Inter Info   
[85], [86]
D1608
 
Tolvaptan
 
C26H25ClN2O3
 
216237 
Moderate    Inter Info   
[119]
   Increased risk of nephrotoxicity Drug Num:  4
Drug ID
 
Drug Name
Formula Pubchem ID Severity Level Interaction Detail REF
D0292
 
Ceftazidime
 
C22H22N6O7S2
 
5481173 
Moderate    Inter Info   
[46], [42]
D0724
 
Givosiran
 
C78H139N11O30
 
119058042 
Moderate    Inter Info   
[46], [42]
D1304
 
Plazomicin
 
C25H48N6O10
 
42613186 
Moderate    Inter Info   
[46], [42]
D1526
 
Tacrolimus
 
C44H69NO12
 
445643 
Moderate    Inter Info   
[46], [42]
   Increased risk of photosensitivity reactions Drug Num:  1
Drug ID
 
Drug Name
Formula Pubchem ID Severity Level Interaction Detail REF
D1314
 
Porfimer sodium
 
C68H74N8O11
 
135577896 
Moderate    Inter Info   
[109], [42], [110]
   Increased risk of prolong QT interval Drug Num:  3
Drug ID
 
Drug Name
Formula Pubchem ID Severity Level Interaction Detail REF
D0149
 
Bedaquiline
 
C32H31BrN2O2
 
5388906 
Minor    Inter Info   
[77], [46], [42], [128], [129], [130], [131]
D0554
 
Efavirenz
 
C14H9ClF3NO2
 
64139 
Minor    Inter Info   
[77], [46], [42], [128], [129], [130], [131]
D1682
 
Vardenafil
 
C23H32N6O4S
 
135400189 
Minor    Inter Info   
[77], [46], [42], [128], [129], [130], [131]
   Potentiated the pharmacological effects (Unspecific) Drug Num:  1
Drug ID
 
Drug Name
Formula Pubchem ID Severity Level Interaction Detail REF
D1366
 
Pyrimethamine
 
C12H13ClN4
 
4993 
Moderate    Inter Info   
[42], [65]
      Pharmacodynamic antagonistic effects
   Antagonize the effect of vaccine/toxoid Drug Num:  2
Drug ID
 
Drug Name
Formula Pubchem ID Severity Level Interaction Detail REF
D1914
 
Typhoid vaccine (live)
 
NA
 
NA
Major    Inter Info   
[42], [43], [44]
D1693
 
Vibrio cholerae CVD 103-HgR strain live antigen (live)
 
NA
 
NA
Major    Inter Info   
[45]
   Attenuated pharmacological effects (Unspecific) Drug Num:  6
Drug ID
 
Drug Name
Formula Pubchem ID Severity Level Interaction Detail REF
D1830
 
Leucovorin
 
C20H23N7O7
 
135403648 
Major    Inter Info   
[39], [40], [41]
D1832
 
Levoleucovorin
 
C20H23N7O7
 
135398559 
Major    Inter Info   
[39], [40], [41]
D0688
 
Folic acid
 
C19H19N7O6
 
135398658 
Moderate    Inter Info   
[42], [49], [50]
D1884
 
Sapropterin
 
C9H15N5O3
 
135398654 
Moderate    Inter Info   
[46], [72]
D0145
 
Balsalazide
 
C17H15N3O6
 
54585 
Moderate    Inter Info   
[79]
D1287
 
Picosulfuric acid
 
C18H15NO8S2
 
5243 
Moderate    Inter Info   
[99], [100], [101]
References
1 Product Information. Tikosyn (dofetilide) Pfizer US Pharmaceuticals, Atlanta, GA.
2 Abel S, Nichols DJ, Brearley CJ, Eve MD "Effect of cimetidine and ranitidine on pharmacokinetics and pharmacodynamics of a single dose of dofetilide." Br J Clin Pharmacol 49 (2000): 64-71.[PMID: 10606839]
3 Johnson BF, Cheng SL, Venitz J "Transient kinetic and dynamic interactions between verapamil and dofetilide, a class III antiarrhythmic." J Clin Pharmacol 41 (2001): 1248-56.[PMID: 11697758]
4 Canaday DH, Johnson JR "Hyperkalemia in elderly patients receiving standard doses of trimethoprim-sulfamethoxazole." Ann Intern Med 120 (1994): 438. [PMID: 8304666]
5 Witt JM, Koo JM, Danielson BD "Effect of standard-dose trimethoprim/sulfamethoxazole on the serum potassium concentration in elderly men." Ann Pharmacother 30 (1996): 347-50. [PMID: 8729886]
6 Alappan R, Perazella MA, Buller GK "Hyperkalemia in hospitalized patients treated with trimethoprim-sulfamethoxazole." Ann Intern Med 124 (1996): 316-20. [PMID: 8554227]
7 Perlmutter EP, Sweeney D, Herskovits G, Kleiner M "Case report: severe hyperkalemia in a geriatric patient receiving standard doses of trimethoprim-sulfamethoxazole." Am J Med Sci 311 (1996): 84-5. [PMID: 8615380]
8 Perazella MA, Mahnensmith RL "Trimethoprim-sulfamethoxazole: hyperkalemia is an important complication regardless of dose." Clin Nephrol 46 (1996): 187-92. [PMID: 8879854]
9 Marinella MA "Trimethoprim-sulfamethoxazole associated with hyperkalemia." West J Med 167 (1997): 356-8. [PMID: 9392994]
10 Hsu I, Wordell CJ "Hyperkalemia and high-dose trimethoprim/sulfamethoxazole." Ann Pharmacother 29 (1995): 427-9. [PMID: 7633023]
11 Antoniou T, Gomes T, Juurlink DN, Loutfy MR, Glazier RH, Mamdani MM "Trimethoprim-sulfamethoxazole-induced hyperkalemia in patients receiving inhibitors of the renin-angiotensin system: a population-based study." Arch Intern Med 170 (2010): 1045-9. [PMID: 20585070]
12 Velazquez H, Perazella MA, Wright FS, Ellison DH "Renal mechanism of trimethoprim-induced hyperkalemia." Ann Intern Med 119 (1993): 296-301. [PMID: 8328738]
13 Marinella MA "Reversible hyperkalemia associated with trimethoprim-sulfamethoxazole." Am J Med Sci 310 (1995): 115-7. [PMID: 7668307]
14 Choi MJ, Fernandez PC, Patnaik A, Coupaye-Gerard B, D'Andrea D, Szerlip H, Kleyman TR "Brief report: trimethoprim-induced hyperkalemia in a patient with AIDS." N Engl J Med 328 (1993): 703-6. [PMID: 8433730]
15 Lin SH, Kuo AA, Yu FC, Lin YF "Reversible voltage-dependent distal renal tubular acidosis in a patient receiving standaard doses of trimethoprim-sulphamethoxazole." Nephrol Dial Transplant 12 (1997): 1031-33. [PMID: 9175064]
16 Thomas RJ "Severe hyperkalemia with trimethoprim-quinapril." Ann Pharmacother 30 (1996): 413-4. [PMID: 8729901]
17 Marinella MA "Severe hyperkalemia associated with trimethoprim-sulfamethoxazole and spironolactone." Infect Dis Clin Pract 6 (1997): 256-8.
18 Lawson DH, O'Connor PC, Jick H "Drug attributed alterations in potassium handling in congestive cardiac failure." Eur J Clin Pharmacol 23 (1982): 21-5. [PMID: 7128669]
19 Lawson DH "Adverse reactions to potassium chloride." Q J Med 43 (1974): 433-40. [PMID: 4424028]
20 Perazella MA, Alappan R, Buller GK "Hyperkalemia and trimethoprim-sulfamethoxazole." Ann Intern Med 125 (1996): 1015. [PMID: 8929019]
21 Noto H, Kaneko Y, Takano T, Kurokawa K "Severe hyponatremia and hyperkalemia induced by trimethoprim-sulfamethoxazole in patients with Pneumocystis carinii pneumonia." Intern Med 34 (1995): 96-9. [PMID: 7727887]
22 Greenberg S, Reiser IW, Chou SY, Porush JG. Trimethoprim-sulfamethoxazole induces reversible hyperkalemia.?Ann Intern Med. 1993;119(4):291-295. [PMID: 8328737]
23 Mihm LB, Rathbun RC, Resmantargoff BH "Hyperkalemia associated with high-dose trimethoprim-sulfamethoxazole in a patient with the acquired immunodeficiency syndrome." Pharmacotherapy 15 (1995): 793-7. [PMID: 8602391]
24 Product Information. Bactrim (trimethoprim-sulfamethoxazole). Roche Laboratories, Nutley, NJ.
25 Mori H, Kuroda Y, Imamura S, et al "Hyponatremia and/or hyperkalemia in patients treated with the standard dose of trimethoprim-sulfamethoxazole." Intern Med 42 (2003): 665-9. [PMID: 12924488]
26 Lee SW, Park SW, Kang JM "Intraoperative hyperkalemia induced by administration of trimethoprim-sulfamethoxazole in a patient receiving angiotensin receptor blockers." J Clin Anesth 26 (2014): 427-8. [PMID: 25128254]
27 Perazella MA, Mahnensmith RL "Hyperkalemia in the elderly: drugs exacerbate impaired potassium homeostasis." J Gen Intern Med 12 (1997): 646-56. [PMID: 9346463]
28 Martin J, Mourton S, Nicholls G "Severe hyperkalaemia with prescription of potassium-retaining agents in an elderly patient." N Z Med J 116 (2003): U542. [PMID: 14513088]
29 Modest GA, Price B, Mascoli N "Hyperkalemia in elderly patients receiving standard doses of trimethoprim-sulfamethoxazole." Ann Intern Med 120 (1994): 437. [PMID: 8304664]
30 Perazella MA "Drug-induced hyperkalemia: old culprits and new offenders." Am J Med 109 (2000): 307-14. [PMID: 10996582]
31 Marcy TR, Ripley TL "Aldosterone antagonists in the treatment of heart failure." Am J Health Syst Pharm 63 (2006): 49-58. [PMID: 16373465]
32 Koc M, Bihorac A, Ozener CI, Kantarci G, Akoglu E "Severe hyperkalemia in two renal transplant recipients treated with standard dose of trimethoprim-sulfamethoxazole." Am J Kidney Dis 36 (2000): u59-64. [PMID: 10977811]
33 Bugge JF "Severe hyperkalaemia induced by trimethoprim in combination with an angiotensin-converting enzyme inhibitor in a patient with transplanted lungs." J Intern Med 240 (1996): 249-51. [PMID: 8918517]
34 Smith GW, Cohen SB "Hyperkalaemia and non-oliguric renal failure associated with trimethoprim." Br Med J 308 (1994): 454. [PMID: 8124180]
35 Eiam-Ong S, Kurtzman NA, Sabatini S "Studies on the mechanism of trimethoprim-induced hyperkalemia." Kidney Int 49 (1996): 1372-8. [PMID: 8731102]
36 Fouche R, Bernardin G, Roger PM, Corcelle P, Simler JM, Mattei M "Hyperkaliemia in a patient given high-dose trimethoprim-sulfamethoxazole." Presse Med 25 (1996): 2044. [PMID: 9082385]
37 Pennypacker LC, Mintzer J, Pitner J "Hyperkalemia in elderly patients receiving standard doses of trimethoprim-sulfamethoxazole." Ann Intern Med 120 (1994): 437. [PMID: 8304665]
38 Greenberg S, Reiser IW, Chou SY "Hyperkalemia with high-dose trimethoprim-sulfamethoxazole therapy." Am J Kidney Dis 22 (1993): 603-6. [PMID: 8213804]
39 Bozzette SA, Forthal D, Sattler FR, Kemper C, Richman DD, Tilles JG, Leedom J, Mccutchan JA "The tolerance for zidovudine plus thrice weekly or daily trimethoprim-sulfamethoxazole with and without leucovorin for primary prophylaxis in advanced HIV disease." Am J Med 98 (1995): 177-82. [PMID: 7847434]
40 Product Information. Levoleucovorin (levoleucovorin). Spectrum Chemical, Gardena, CA.
41 Razavi B, Lund B, Allen BL, Schlesinger L "Failure of trimethoprim/sulfamethoxazole prophylaxis for Pneumocystis carinii pneumonia with concurrent leucovorin use." Infection 30 (2002): 41-2. [PMID: 11876516]
42 Cerner Multum, Inc. "UK Summary of Product Characteristics.".
43 UK government "Typhoid.".
44 American Medical Association, Division of Drugs and Toxicology "Drug evaluations annual 1994." Chicago, IL: American Medical Association (1994).
45 Product Information. Vaxchora (cholera vaccine, live). PaxVax, Miami, FL.
46 Cerner Multum, Inc. "Australian Product Information.".
47 Agencia Espaola de Medicamentos y Productos Sanitarios Healthcare "Centro de informacion online de medicamentos de la AEMPS - CIMA.".
48 Guo LQ, Yamazoe Y "Inhibition of cytochrome P450 by furanocoumarins in grapefruit juice and herbal medicines." Acta Pharmacol Sin 25 (2004): 129-36. [PMID: 14769198]
49 Mulenga M, Malunga P, Bennett S. et.al "Folic acid treatment of Zambian children with moderate to severe malaria anemia." Am J Trop Med Hyg 74 (2006): 986-90
50 Product Information. Folic Acid (folic acid). Method Pharmaceuticals, LLC, Arlington, TX.
51 Product Information. Glucophage (metformin). Bristol-Myers Squibb, Princeton, NJ.
52 Somogyi A, Stockley C, Keal J, Rolan P, Bochner F "Reduction of metformin renal tubular secretion by cimetidine in man." Br J Clin Pharmacol 23 (1987): 545-51. [PMID: 3593625]
53 Antoniou T, Gomes T, Mamdani MM, Juurlink DN "Trimethoprim/sulfamethoxazole-induced phenytoin toxicity in the elderly: a population-based study." Br J Clin Pharmacol 71 (2011): 544-9. [PMID: 21395647]
54 Cerner Multum, Inc. "Canadian Product Information.".
55 Dasgupta A, Dennen DA, Dean R, McLawhon RW "Displacement of phenytoin from serum protein carriers by antibiotics: studies with ceftriaxone, nafcillin, and sulfamethoxazole." Clin Chem 37 (1991): 98-100. [PMID: 1988217]
56 Gillman MA "Phenytoin toxicity and co-trimazole." Ann Intern Med 102 (1985): 559. [PMID: 3872091]
57 Hansen JM, Kampmann JP, Siersback-Nielsen K, et al. "The effect of different sulfonamides on phenytoin metabolism in man." Acta Med Scand Suppl 624 (1979): 106-10. [PMID: 284708]
58 Hines LE, Murphy JE "Potentially harmful drug-drug interactions in the elderly: a review." Am J Geriatr Pharmacother 9 (2011): 364-77. [PMID: 22078863]
59 Ilario MJ, Ruiz JE, Axiotis CA "Acute fulminant hepatic failure in a woman treated with phenytoin and trimethoprim-sulfamethoxazole." Arch Pathol Lab Med 124 (2000): 1800-3. [PMID: 11100060]
60 Komatsu T, Yamazaki H, Asahi S, Gillam EMJ, Guengerich FP, Nakajima M, Yokoi T "Formation of a dihydroxy metabolite of phenytoin in human liver microsomes/cytosol: Roles of cytochromes P4502C9, 2C19, and 3A4." Drug Metab Disposition 28 (2000): 1361-8. [PMID: 11038165]
61 Product Information. Dilantin (phenytoin). Parke-Davis, Morris Plains, NJ.
62 Product Information. Trimethoprim (trimethoprim). Teva Pharmaceuticals USA, North Wales, PA.
63 Wen X, Wang JS, Backman JT, Laitila J, Neuvonen PJ "Trimethoprim and sulfamethoxazole are selective inhibitors of CYP2C8 and CYP2C9, respectively." Drug Metab Dispos 30 (2002): 631-635. [PMID: 12019187]
64 Wilcox JB "Phenytoin intoxication and cotrimoxazole." N Z Med J 94 (1981): 235-6. [PMID: 6975449]
65 Multum Information Services, Inc. Expert Review Panel.
66 Baldwin SJ, Clarke SE, Chenery RJ "Characterization of the cytochrome P450 enzymes involved in the in vitro metabolism of rosiglitazone." Br J Clin Pharmacol 48 (1999): 424-32. [PMID: 10510156]
67 Hruska MW, Amico JA, Langaee TY, Ferrell RE, Fitzgerald SM, Frye RF "The effect of trimethoprim on CYP2C8 mediated rosiglitazone metabolism in human liver microsomes and healthy subjects." Br J Clin Pharmacol 59 (2005): 70-9. [PMID: 15606443]
68 Niemi M, Backman JT, Granfors M, Laitila J, Neuvonen M, Neuvonen PJ "Gemfibrozil considerably increases the plasma concentrations of rosiglitazone." Diabetologia 46 (2003): 1319-23. [PMID: 12898007]
69 Niemi M, Backman JT, Neuvonen PJ "Effects of trimethoprim and rifampin on the pharmacokinetics of the cytochrome P450 2C8 substrate rosiglitazone." Clin Pharmacol Ther 76 (2004): 239-49. [PMID: 15371985]
70 Product Information. Avandia (rosiglitazone) SmithKline Beecham, Philadelphia, PA.
71 Scheen AJ "Pharmacokinetic interactions with thiazolidinediones." Clin Pharmacokinet 46 (2007): 1-12. [PMID: 17201456]
72 Product Information. Kuvan (sapropterin). BioMarin Pharmaceutical Inc, Novato, CA.
73 Product Information. Remodulin (treprostinil). United Therapeutics Corp, Silver Spring, MD.
74 Agencia Espaola de Medicamentos y Productos Sanitarios Healthcare "Centro de informacion online de medicamentos de la AEMPS - CIMA.".
75 Bailey RR "Leukopenia due to a trimethoprim-azathioprine interaction." N Z Med J 97 (1984): 739. [PMID: 6595562]
76 Berg KJ, Gjellestad A, Nordby G, et al "Renal effects of trimethoprim in ciclosporin- and azathioprine-treated kidney-allografted patients." Nephron 53 (1989): 218-22. [PMID: 2677807]
77 Canadian Pharmacists Association.
78 Product Information. Imuran (azathioprine). Glaxo Wellcome, Research Triangle Park, NC.
79 Product Information. Colazal (balsalazide) Salix Pharmaceuticals, Palo Alto, CA.
80 Product Information. Mektovi (binimetinib). Array BioPharma Inc., Boulder, CO.
81 Bhatia RS, Uppal R, Malhi R, Behera D, Jindal SK "Drug interaction between rifampicin and cotrimazole in patients with tuberculosis." Hum Exp Toxicol 10 (1991): 419-21. [PMID: 1687853]
82 Ribera E, Pou L, Fernandez-Sola A, et al. "Rifampin reduces concentrations of trimethoprim and sulfamethoxazole in serum in human immunodeficiency virus-infected patients." Antimicrob Agents Chemother 45 (2001): 3238-41. [PMID: 11600390]
83 Ribera E, FernandezSola A, Juste C, Rovira A, Romero FJ, ArmadansGil L, Ruiz I, Ocana I, Pahissa A "Comparison of high and low doses of trimethoprim-sulfamethoxazole for primary prevention of toxoplasmic encephalitis in human immunodeficiency virus-infected patients." Clin Infect Dis 29 (1999): 1461-6. [PMID: 10585796]
84 EMEA. European Medicines Agency "EPARs. European Union Public Assessment Reports.".
85 Product Information. Yasmin (drospirenone-ethinyl estradiol) Berlex Laboratories, Richmond, CA.
86 Ponce SP, Jennings AE, Madias NE, Harrington JT "Drug-induced hyperkalemia." Medicine (Baltimore) 64 (1985): 357-70. [PMID: 2865667]
87 Product Information. Voraxaze (glucarpidase). BTG International Inc, West Conshohocken, PA.
88 Product Information. Indium Oxyquinoline In-111 (indium oxyquinoline In-111). GE Healthcare, Princeton, NJ.
89 EMA. European Medicines Agency. European Union "EMA - List of medicines under additional monitoring.".
90 Karonen T, Filppula A, Laitila J, Niemi M, Neuvonen PJ, Backman JT "Gemfibrozil Markedly Increases the Plasma Concentrations of Montelukast: A Previously Unrecognized Role for CYP2C8 in the Metabolism of Montelukast." Clin Pharmacol Ther (2010):. [PMID: 20592724]
91 Product Information. Singulair (montelukast). Merck & Co, Inc, West Point, PA.
92 Bergmann TK, Filppula AM, Launiainen T, Nielsen F, Backman J, Brosen K "Neurotoxicity and low paclitaxel clearance associated with concomitant clopidogrel therapy in a 60 year old Caucasian woman with ovarian carcinoma." Br J Clin Pharmacol (2015):. [PMID: 26446447]
93 Bun SS, Ciccolini J, Bun H, Aubert C, Catalin J "Drug interactions of paclitaxel metabolism in human liver microsomes." J Chemother 15 (2003): 266-74. [PMID: 12868554]
94 Jamis-Dow CA, Klecker RW, Katki AG, Collins JM "Metabolism of Taxol by human liver microsomes and effect of inhibitors (Meeting abstract)." Proc Annu Meet Am Assoc Cancer Res 34 (1993): a21981993.
95 Product Information. Abraxane (paclitaxel protein-bound). American Pharmaceutical Partners, Schaumberg, IL.
96 Product Information. Taxol (paclitaxel). Bristol-Myers Squibb, Princeton, NJ.
97 Spencer CM, Faulds D "Paclitaxel. A review of its pharmacodynamic and pharmacokinetic properties and therapeutic potential in the treatment of cancer." Drugs 48 (1994): 794-847. [PMID: 7530632]
98 Starr SP, Hammann F, Gotta V, et al. "Pharmacokinetic interaction between taxanes and amiodarone leading to severe toxicity." Br J Clin Pharmacol 450 (2016): 22-27. [PMID: 27868228]
99 Product Information. Prepopik (citric acid/Mg oxide/Na picosulfate). Ferring Pharmaceuticals Inc, Tarrytown, NY.
100 MHRA. Medicines and Healthcare Regulatory Agency (general site Reference).
101 Product Information. Clenpiq (citric acid/Mg oxide/Na picosulfate). Ferring Pharmaceuticals Inc, Tarrytown, NY.
102 Aquilante CL, Kosmiski LA, Bourne DW, et al. "Impact of the CYP2C8 *3 polymorphism on the drug-drug interaction between gemfibrozil and pioglitazone." Br J Clin Pharmacol 75 (2013): 217-26. [PMID: 22625877]
103 Daily EB, Aquilante CL "Cytochrome P450 2C8 pharmacogenetics: a review of clinical studies." Pharmacogenomics 10 (2009): 1489-510. [PMID: 19761371]
104 Deng LJ, Wang F, Li HD "Effect of gemfibrozil on the pharmacokinetics of pioglitazone." Eur J Clin Pharmacol 61 (2005): 831-6. [PMID: 16283275]
105 Jaakkola T, Backman JT, Neuvonen M, Neuvonen PJ "Effects of gemfibrozil, itraconazole, and their combination on the pharmacokinetics of pioglitazone." Clin Pharmacol Ther 77 (2005): 404-14. [PMID: 15900286]
106 Jaakkola T, Laitila J, Neuvonen PJ, Backman JT "Pioglitazone is metabolised by CYP2C8 and CYP3A4 in vitro: potential for interactions with CYP2C8 inhibitors." Basic Clin Pharmacol Toxicol 99 (2006): 44-51. [PMID: 16867170]
107 Product Information. Actos (pioglitazone) Takeda Pharmaceuticals America, Lincolnshire, IL.
108 Totah RA, Rettie AE "Cytochrome P450 2C8: substrates, inhibitors, pharmacogenetics, and clinical relevance." Clin Pharmacol Ther 77 (2005): 341-52. [PMID: 15900280]
109 Blakely KM, Drucker AM, Rosen CF "Drug-induced photosensitivity-an update: Culprit drugs, prevention and management." Drug Saf 42 (2019): 827-47. [PMID: 30888626]
110 Product Information. Photofrin (porfimer). Sanofi Winthrop Pharmaceuticals, New York, NY.
111 Harron D, Brogden R "Acecaindie (N-acetylprocainamide)." Drugs 39 (1990): 720-40
112 Kosoglou T, Rocci M, Vlasses P "Trimethoprim alters the disposition of procainamide and N-acetylprocainamide." Clin Pharmacol Ther 44 (1988): 467-77
113 Vlasses P, Kosoglou T, Chase S, et al "Trimethoprim inhibition of the renal clearance of procainamide and N-acetylprocainamide." Arch Intern Med 149 (1989): 1350-3
114 Bidstrup TB, Bjornsdottir I, Sidelmann UG, Thomsen MS, Hansen KT "CYP2C8 and CYP3A4 are the principal enzymes involved in the human in vitro biotransformation of the insulin secretagogue repaglinide." Br J Clin Pharmacol 56 (2003): 305-14. [PMID: 12919179]
115 Hatorp V "Clinical pharmacokinetics and pharmacodynamics of repaglinide." Clin Pharmacokinet 41 (2002): 471-83. [PMID: 12083976]
116 Niemi M, Kajosaari LI, Neuvonen M, Backman JT, Neuvonen PJ "The CYP2C8 inhibitor trimethoprim increases the plasma concentrations of repaglinide in healthy subjects." Br J Clin Pharmacol 57 (2004): 441-7. [PMID: 15025742]
117 Skerjanec A, Wang J, Maren K, Rojkjaer L "Investigation of the pharmacokinetic interactions of deferasirox, a once-daily oral iron chelator, with midazolam, rifampin, and repaglinide in healthy volunteers." J Clin Pharmacol 50 (2010): 205-13. [PMID: 19940232]
118 Product Information. Uptravi (selexipag). Actelion Pharmaceuticals US Inc, South San Francisco, CA.
119 Product Information. Samsca (tolvaptan). Otsuka American Pharmaceuticals Inc, Rockville, MD.
120 Product Information. Tukysa (tucatinib). Seattle Genetics Inc, Bothell, WA.
121 Product Information. Hivid (zalcitabine). Roche Laboratories, Nutley, NJ.
122 Colchicine: serious interactions. Prescrire Int 17 (2008): 151-3. [PMID: 19492485]
123 Goldbart A, Press J, Sofer S, Kapelushnik J "Near fatal acute colchicine intoxication in a child. A case report." Eur J Pediatr 159 (2000): 895-7. [PMID: 11131346]
124 Vandenberghe K, Gosris M, Van Hecke PV, Van Leemputte M, Vangerven L, Hespel P "Long-term creatine intake is beneficial to muscle performance during resistance training." J Appl Physiol 83 (1997): 2055-63. [PMID: 9390981]
125 Becquemont L, Verstuyft C, Kerb R, et al. "Effect of grapefruit juice on digoxin pharmacokinetics in humans." Clin Pharmacol Ther 70 (2001): 311-6. [PMID: 11673746]
126 Darcy PF "Nutrient-drug interactions." Adverse Drug React Toxicol Rev 14 (1995): 233-54. [PMID: 8845456]
127 Petersen P, Kastrup J, Bartram R, Hansen J "Digoxin-trimethoprim interaction." Acta Med Scand 217 (1985): 423-7
128 Crouch MA, Limon L, Cassano AT "Clinical relevance and management of drug-related QT interval prolongation." Pharmacotherapy 23 (2003): 881-908. [PMID: 12885102]
129 Darpo B "Spectrum of drugs prolonging QT interval and the incidence of torsades de pointes." Eur Heart J Suppl 3(Suppl K) (2001): K70-80.
130 Lopez JA, Harold JG, Rosenthal MC, Oseran DS, Schapira JN, Peter T "QT prolongation and torsades de pointes after administration of trimethoprin-sulfamethoxazole." Am J Cardiol 59 (1987): 376-7. [PMID: 3492908]
131 Wiener I, Rubin D, Martinez E, et al "QT prolongation and paroxysmal ventricular tachycardia occurring during fever following trimethoprim-sulfamethoxazole administration." Mt Sinai J Med 48 (1981): 53-5. [PMID: 6970886]
132 Product Information. Valcyte (valganciclovir) Roche Laboratories, Nutley, NJ.
133 Ujhelyi MR, Bottorff MB, Schur M, et al. "Aging effects on the organic basic transporter and stereoselective renal clearance." Clin Pharmacol Ther 62 (1997): 117-28. [PMID: 9284847]